Viral clearance is important and mandatory for biologics as these products are used for the treatment and diagnostic purposes in humans. As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologics, injectables
Viral Clearance Market By Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Inactivation, Removal (Precipitation), Detection (PCR, ELISA)) & End User (Pharmaceutical & Biotechnology, CROs, Research Institute)
The global viral clearance market is projected to reach USD 510.3 million by 2020 from USD 285.5 million in 2015, at a CAGR of 12.3% from 2015 to 2020.
Get Sample Copy for more professional insights Here@ www.reportsnreports.com/contacts/r….aspx?name=522180
The global viral clearance market is projected to reach USD 510.3 million by 2020 from USD 285.5 million in 2015, at a CAGR of 12.3% from 2015 to 2020. The major drivers for the market include increase in pharmaceutical and biological industries and increasing number of new drug launches.
Over the years, the number of drug approvals in North American countries has increased from 2006 to 2015.The increasing number of drug approvals will boost the viral clearance market.
This report segments the global viral clearance market is segmented based on method, end user, application, and geography. The method segments included in the report are viral detection method, viral removal method, and viral inactivation method.
The viral detection method is further subsegmented in to plaque assays, PCR, ELISA, and other viral detection method. Other viral detection method includes western blot, transmission EM, in vivo assay, in vitro assay, and NGS (Next Generation Sequencing).
The viral removal method is further subsegmented in to chromatography, nano filtration, and precipitation. The viral inactivation method is further subsegmented in to solvent detergent method, pasteurization, and other viral inactivation method.
Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light.
Report on Viral clearance Market 2017-2020 spreads across 165 pages profiling 10 companies and supported with 76 tables and 89 figures available at www.reportsnreports.com/contacts/d…aspx?name=522180
*Top 10 Companies Analysed for This Study are
(Overview, Financials, Products & Services, Strategy, & Developments)* Charles River Laboratories International, Inc., Lonza Group, Sigma-Aldrich Corporation, SGS S.A., Wuxi Pharmatech (Cayman) Inc., Avance Biosciences Inc., BSL Bioservice, Clean Cells Inc., Merck KGAA, Texcell, Inc.,*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.
Target Audience for this Report:
- Viral clearance product manufacturers and vendors
- Research associations related to pharmaceutical and biotechnological research
- contract research organizations (CROs)
- Various research and consulting firms
- Healthcare institutions
- Research institutes
- Distributors of viral clearance equipment
Key point from table of content
7 Viral Clearance Market, By End User
7.2 Pharmaceutical and Biotechnology Companies
7.3 Contract Research Organizations
8 Viral Clearance Market, By Method
8.2 Viral Detection Method
8.2.1 Plaque Assays
9 Viral Clearance Market, By Region
9.2 North America
10 Competitive Landscape
10.1.1 Strategic Overview
10.2 Leading Players in the Viral Clearance Market
10.3 Competitive Situation and Trends
Browse Here for full Report with TOC: www.reportsnreports.com/reports/52…ast-to-2020.html